Insilico Medicine, Biopharmaceuticals Strike: AI Drug Deal Heads Toward $2.5B
Insilico Medicine and SK Biopharmaceuticals unveiled a milestone collaboration worth up to $2.5 billion to develop ne...
If you want tighter expense control and explicit assignment of funds, zero based budgeting can be worth trying. This intro explains potential gains and a simple starting point.
26,943 articlesInsilico Medicine and SK Biopharmaceuticals unveiled a milestone collaboration worth up to $2.5 billion to develop ne...
Alibaba's KIMI AI model released 2026 price trajectories for XRP, SHIB, and PEPE, highlighting potential upside under...
A breakthrough approval can move a biotech stock in dramatic ways. This guide breaks down how to assess the upside, m...
A security advisory from Ethereum L2 Taiko warns users to pull funds from Taiko-linked bridges after a state verifica...
stifel just predicted bitcoin could fall toward $38,000, a chart-based call rooted in 15-year crash bottoms that has ...
AMD has surged dramatically, but the AI data-center boom could still offer upside. This guide explores whether late a...
Strobe Finance, the XRP Ledger EVM Sidechain’s sole native lending protocol, is winding down. Users must repay loans ...
Nvidia is moving beyond chips into AI agents, changing how businesses deploy AI and how investors should value the co...
The chatter around a SpaceX IPO has investors buzzing, but hype can blur fundamentals. This guide breaks down what to...
LNG demand is primed to rise dramatically as the world leans on cleaner fuels. This guide highlights why the trend ma...
MSCI stock is facing a sharp move lower after quarterly results and an strategic shift. This article explains the dri...
When a major investor dumped million from a high-yield closed-end fund, it sent a clear message about risk, liquidity...